Franklin Resources
MNTA

Franklin Resources’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Franklin Resources’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-791,900
Closed -$20.8M – 1554
2018
Q3 		$20.8M Sell
791,900
-86,200
-10% -$2.33M 0.01% 778
2018
Q2 		$18M Buy
+878,100
New +$18.8M 0.01% 802
2014
Q2 		– Sell
-586,700
Closed -$6.83M – 1588
2014
Q1 		$6.83M Buy
+586,700
New +$9.94M ﹤0.01% 1102

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources's MNTA Position: Q4 2018 in Review

Franklin Resources sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 791,900 shares — an estimated $20.8M sold.

Franklin Resources first reported a position in MNTA in Q1 2014 and held it in 3 quarters. The position peaked at $20.8M in Q3 2018. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

  • Franklin Resources reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Franklin Resources sold 791,900 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $20.8M.
  • Franklin Resources first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
  • Franklin Resources's Momenta Pharmaceuticals, Inc. position peaked at $20.8M in Q3 2018.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on Franklin Resources's 13F filing for Q4 2018, filed 12 Feb 2019.